losartan-potassium and Heart-Septal-Defects--Ventricular

losartan-potassium has been researched along with Heart-Septal-Defects--Ventricular* in 3 studies

Other Studies

3 other study(ies) available for losartan-potassium and Heart-Septal-Defects--Ventricular

ArticleYear
Cardiogenic shock complicating myocardial infarction in a doped athlete.
    Acute cardiac care, 2009, Volume: 11, Issue:4

    Abuse of doping agents may pose a higher risk for heart disease including acute myocardial infarction. We report the case of a 50-year-old body-builder Caucasian man with a long-standing abuse of nandrolone and erythropoietin that developed a ventricular septal defect following acute myocardial infarction. This mechanical complication led to cardiogenic shock ultimately treated with the implantation of a circulatory support by means of extracorporeal membrane oxygenation. The patient subsequently underwent orthotopic heart transplantation. The association of intense isometric exercise, abuse of erythropoietin and nandrolone is likely to have predisposed to coronary thrombus formation and acute myocardial infarction, as the patient presented no traditional cardiovascular risk factors.

    Topics: Anabolic Agents; Doping in Sports; Erythropoietin; Heart Septal Defects, Ventricular; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Infarction; Nandrolone; Shock, Cardiogenic; Weight Lifting

2009
Bloodless cardiac surgery and the pediatric patient: a case study.
    Perfusion, 2008, Volume: 23, Issue:2

    Peri-operative transfusion of blood or blood products is associated with increased morbidity and mortality after cardiac surgery. However, excessive hemodilution as a result of avoiding the use of homologous blood products can also lead to decreased oxygen delivery to vital end organs and dilutional coagulopathy. This is particularly challenging in pediatric cardiac surgery where there is a large discrepancy between the patient circulating blood volume and the priming volume of the cardiopulmonary bypass (CPB) circuit. Strategies to avoid the use of homologous blood products during pediatric cardiac surgery must also incorporate miniaturization of the CPB circuit and other bypass techniques in order to avoid problems with excessive hemodilution. We report a 5.9 kg male infant who underwent successful surgical correction of a ventricular septal defect without the use of homologous blood transfusion. Our strategies included the pre-operative administration of erythropoietin and iron to increase red blood cell mass, acute normovolemic hemodilution (ANH) before the institution of CPB, retrograde autologous priming (RAP), cell salvage, continuous ultrafiltration, vacuum-assisted venous drainage to minimize the circuit size and priming volume, and the use of near infrared spectroscopy (NIRS) to monitor the patient during the entire procedure. The utilization of these strategies is now standard for our entire pediatric cardiac surgical population.

    Topics: Blood Transfusion, Autologous; Cardiac Surgical Procedures; Erythropoietin; Heart Septal Defects, Ventricular; Hemodilution; Humans; Infant; Iron; Male; Preoperative Care

2008
Correction of congenital heart defects in Jehovah's Witness children.
    The Thoracic and cardiovascular surgeon, 2004, Volume: 52, Issue:3

    Between August 1989 and July 2003 14 Jehovah's Witness children with congenital heart defects (CHD) aged under 14 years (median 2.9 years) and with a median weight of 14 kg underwent 16 operations with cardiopulmonary bypass (CPB). Five children had been operated on previously between one to three times. Preoperatively, 7 children were prepared with oral iron supplementation and 10 received erythropoietin. Mean hemoglobin (Hb) at admission was 14.4 g/dl (range 10.9 - 19.2). The cardiopulmonary bypass (CPB) circuit was modified to reduce total priming volume. High doses of aprotinin were administered. The modified ultrafiltration (MUF) circuit, used in 7 patients, was parallel to the ECC circuit with continuous circulation of the blood through a small shunt between the arterial and venous lines. Operations performed consisted of VSD closure (3 pts.), ASD closure (3 pts.), Fontan operation (2 pts.), and complete AV canal correction, aortic commissurotomy, Ross operation, Glenn shunt, cor triatriatum correction, MV reconstruction combined with left outflow tract stenosis resection, correction of absent pulmonary valve syndrome, and correction of tetralogy of Fallot in one patient each. There were no deaths. Mean duration of CPB was 192 min and mean aortic cross-clamp time 40 min. The Hb value at the end of the operation was 4.9 - 14.5 g/dl (mean 9.6) and at discharge it was 7.1 - 14.5 g/dl (mean 15.5). No blood or blood products were used in any patient.. Bloodless cardiac surgery with and without CPB can be safely performed in Jehovah's Witness infants and children.

    Topics: Aprotinin; Cardiopulmonary Bypass; Child; Child, Preschool; Deamino Arginine Vasopressin; Erythropoietin; Heart Defects, Congenital; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Hemoglobins; Hemostatics; Humans; Infant; Jehovah's Witnesses

2004